EVALUATION OF HUMAN CYTOMEGALOVIRUS LATENCY IN ALVEOLAR MACROPHAGES

被引:16
作者
FAJAC, A
VIDAUD, M
LEBARGY, F
STEPHAN, F
RICCI, S
GESLIN, P
GOOSSENS, M
BERNAUDIN, JF
机构
[1] HOP TENON, HISTOL LAB, SERV HISTOL BIOL, F-75020 PARIS, FRANCE
[2] HOP HENRI MONDOR, INSERM, U139, F-94010 CRETEIL, FRANCE
[3] HOP HENRI MONDOR, INSERM, U91, F-94010 CRETEIL, FRANCE
[4] HOP HENRI MONDOR, BIOCHEM LAB, F-94010 CRETEIL, FRANCE
[5] HOP INTERCOMMUNAL CRETEIL, MICROBIOL LAB, CRETEIL, FRANCE
关键词
D O I
10.1164/ajrccm.149.2.8306052
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Cytomegalovirus (CMV) pneumonia is a major cause of illness in immunocompromised patients. The sites of human CMV (HCMV) latency are still not clearly defined. The present study was therefore designed to investigate the hypothesis that alveolar macrophages could constitute such a site. DNA extracted from alveolar cells collected by bronchoalveolar lavage and blood mononuclear cells (BMC) from asymptomatic nonimmunocompromised CMV-seropositive and CMV-seronegative patients were investigated. Controls consisted of DNA from a CMV-infected MRCS cell line, BMC and alveolar macrophages from patients with acute CMV infection. Polymerase chain reaction (PCR) was designed for detection of a 290-bp fragment of the promoter region of the major immediate early gene of HCMV conserved within the various HCMV strains and without homology with the human genome. The limit of detection of the method was evaluated to be one HCMV viral copy per 10(4) cells. HCMV DNA was detected in BMC or alveolar cells of all patients with acute CMV infection. In contrast, no HCMV DNA was detected in alveolar cells and BMC from nonimmunocompromised asymptomatic HCMV-seropositive patients. In conclusion, in the present experiment, no latent HCMV could be detected in alveolar cells collected in nonimmunocompromised asymptomatic CMV-seropositive patients.
引用
收藏
页码:495 / 499
页数:5
相关论文
共 35 条
[1]  
ADLER SP, 1983, REV INFECT DIS, V5, P977
[2]  
BOYUM A, 1968, SCAND J CLIN LAB S97, V21, P1
[3]   PATHOGENESIS OF MURINE CYTOMEGALO-VIRUS INFECTION - MACROPHAGE AS A PERMISSIVE CELL FOR CYTOMEGALO-VIRUS INFECTION, REPLICATION AND LATENCY [J].
BRAUTIGAM, AR ;
DUTKO, FJ ;
OLDING, LB ;
OLDSTONE, MBA .
JOURNAL OF GENERAL VIROLOGY, 1979, 44 (AUG) :349-359
[4]   PRIMER-MEDIATED ENZYMATIC AMPLIFICATION OF CYTOMEGALO-VIRUS (CMV) DNA - APPLICATION TO THE EARLY DIAGNOSIS OF CMV INFECTION IN MARROW TRANSPLANT RECIPIENTS [J].
CASSOL, SA ;
POON, MC ;
PAL, R ;
NAYLOR, MJ ;
CULVERJAMES, J ;
BOWEN, TJ ;
RUSSELL, JA ;
KRAWETZ, SA ;
PON, RT ;
HOAR, DI .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1109-1115
[5]  
CORDONNIER C, 1985, AM REV RESPIR DIS, V132, P1118
[6]   EVALUATION OF 3 ASSAYS ON ALVEOLAR-LAVAGE FLUID IN THE DIAGNOSIS OF CYTOMEGALOVIRUS PNEUMONITIS AFTER BONE-MARROW TRANSPLANTATION [J].
CORDONNIER, C ;
ESCUDIER, E ;
NICOLAS, JC ;
FLEURY, J ;
DEFORGES, L ;
INGRAND, D ;
BRICOUT, F ;
BERNAUDIN, JF .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (03) :495-500
[7]  
CRAIGHEAD JE, 1971, AM J PATHOL, V63, P487
[8]  
CROEN KD, 1987, NEW ENGL J MED, V317, P427
[9]  
DEMLER GJ, 1988, J INFECT DIS, V6, P117
[10]   LATENT CYTOMEGALOVIRUS INFECTION IN BLOOD DONORS [J].
DIOSI, P ;
MOLDOVAN, E ;
TOMESCU, N .
BRITISH MEDICAL JOURNAL, 1969, 4 (5684) :660-&